Modernaâs Covid-19 Vaccine Could Widen Immunization Effort
BY PETER LOFTUS â The Wall Street Journal.
Health officials across the U.S. are counting on the arrival of a second Covid-19 vaccine to boost scarce supplies and sidestep logistical issues encountered by the first vaccine, which began distribution this week.
The U.S. Food and Drug Administration may issue an emergency authorization for a vaccine from Moderna Inc. as early as Friday after an advisory panel recommended the agency approve its use. If authorized, Modernaâs vaccine will join a vaccine from Pfizer Inc. and BioNTech SE that received authorization on Dec. 11.
No data Source: Centers for Disease Control and Prevention | Note: No data available for Hawaii, New Mexico, Texas and some counties. Five other states were excluded because more than a quarter of data is missing.
Jump to: The C.D.C. is now reporting people fully vaccinated by county of residence. This data is not available for all states, and is incomplete in others, artificially lowering the published vaccination rates for some counties. Tap on a county to see how much data is missing in each state. The Centers for Disease Control and Prevention said on Sunday about 106.2 million people have received at least one dose of a Covid-19 vaccine, including about 61.4 million people who have been fully vaccinated by Johnson & Johnson’s single-dose vaccine or the two-dose series made by Pfizer-BioNTech and Moderna.